#acc26

#ACC26 is just a few days away! 📆Join me on Sat 3/28 2:30pm CT for How the Cardiology Community Can Combat Medical Misinformation 🤨Is social media still an opportunity to promote evidence-based medicine? #socialmedia #medicine #cardiotwitter
Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦23,107 просмотров • 4 месяцев назад

Among patients with #diabetes but without known significant atherosclerosis, intensive LDL-C lowering with evolocumab plus statin reduced risk of first major cardiovascular event vs placebo in the VESALIUS-CV trial. #ACC26 American College of Cardiology 🎥 Watch the video and read the full article:
JAMA14,124 просмотров • 4 месяцев назад

📹 Watch experts share who they’re most excited to connect w/ at #ACC26! 👇 Get ready for meaningful connections, new ideas, inspiration, & more. Who are you looking forward to meeting? Join the 🌍 cardiovascular community at #ACC26 – 1️⃣ month to go! ➡️
American College of Cardiology12,794 просмотров • 5 месяцев назад

From setup to showtime, everything is coming to life. 🫀 A final walkthrough with #ACC26 Chair Katie Berlacher, MD, MS, FACC, Vice Chair Julie Damp, MD, FACC, and CV Team Lead Kristen Campbell, PharmD, CPP, FACC. 👀 The wait is almost over. Let the #ACC26 experience begin! 🎉
American College of Cardiology10,957 просмотров • 4 месяцев назад

Dr. Saibal Kar and Dr. C. Michael Gibson discuss the CHAMPION-AF trial: Left atrial appendage closure with the WATCHMAN FLX device was non-inferior to DOACs for the composite of CV death, stroke, or systemic embolism among patients with non-valvular AFib. #ACC26 Watch video here:
C. Michael Gibson MD10,732 просмотров • 4 месяцев назад

Drs. Fred M. Kusumoto and Beth Dineen (Hill), DO, FACC share what they’re most excited about at #ACC26, from pre-conference sessions to late-breaking clinical trials. 📹 Watch the video 👇 and learn more about everything ACC.26 has to offer ➡️ #ACCAnywhere #CardioX
American College of Cardiology12,737 просмотров • 5 месяцев назад

Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the MOMENTUM study: Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism, a significantly higher prevalence than previously recognized. #ACC26 Watch video here:
C. Michael Gibson MD10,094 просмотров • 4 месяцев назад

From meaningful connections to memorable moments, #ACC26 is where collaboration comes to life. 🪄 🤝 Network with peers 🫀 Engage with experts ❓ Ask your questions ✨ …and more! Join the excitement, make connections, and be part of the action ➡️
American College of Cardiology11,393 просмотров • 6 месяцев назад
Больше нет контента для загрузки


